Join the Fight Against MDS
Every gift helps patients, caregivers, and healthcare professionals access life-saving resources, support, and education. Together, we can make a difference. Even a small contribution can create a big impact. Thank you for your generosity.
Our Podcast
MDS Professional Report
This podcast series provides important up-to-the-minute information on MDS including diagnosis, treatment and clinical research. The explosion of information on MDS forces us to seek novel, alternative ways to distribute it. Podcasts gives us an easy and popular way to communicate this information in a short time.
![Treatment of lower-risk MDS [MDS Professional Report]](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_160/images.spreaker.com/original/59731ffad6896313dd70ce957e619b02.jpg)
December 15, 2024
4. Treatment of lower-risk MDS [MDS Professional Report]
Prof. Uwe Platzbecker from Leipzig and Prof. Moshe Mittelman from Tel-Aviv in an interesting conversation on the various available therapeutic modalities for patients with lower-risk MDS.
![New trials to address the anemia of lower-risk MDS [MDS Professional Report]](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_160/images.spreaker.com/original/6fb86eb9669a4d2de76fbe628d3c3231.jpg)
March 27, 2024
1. New trials to address the anemia of lower-risk MDS [MDS Professional Report]
Drs Nikolaos Papadantonakis of Emory, Atlanta, US, and Moshe Mittelman, Tel-Aviv, Israel, discuss trials presented in American Society of Hematology (ASH) 2023 meeting. They provide some data on luspatercept, imetelstat, roxodustat and Ker-050.
